Lilly Shares Jump On 7.9% Weight Loss Pill Eli Lilly said on Thursday its experimental pill, orforglipron, led to weight loss of nearly 8% at the highest dose and lowered blood sugar in patients with type 2 diabetes in a late-stage trial. By ryounglao|2025-04-17T10:33:19-04:00April 17, 2025|International News|0 Comments Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: ryounglao Related Posts Walmart Warns Of Higher Prices, Withholds Second-Quarter Profit Guidance Walmart Warns Of Higher Prices, Withholds Second-Quarter Profit Guidance Deere Trims Annual Profit Forecast, Posts Lower Q2 Results On Softer Demand Deere Trims Annual Profit Forecast, Posts Lower Q2 Results On Softer Demand Alibaba Misses Revenue Estimates As It Fights For China E-Commerce Market Dominance Alibaba Misses Revenue Estimates As It Fights For China E-Commerce Market Dominance Oil Extends Drop As Trump Says US Is Closer To Deal With Iran Oil Extends Drop As Trump Says US Is Closer To Deal With Iran Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Δ
Leave A Comment